Secondary outcomes were PE-related mortality within 90 days, the recurrence of an objectively confirmed, symptomatic VTE during the whole follow-up, defined as a fatal or new non-fatal PE or new deep vein thrombosis , and the length of hospital stay (LOS) of patients who were hospitalized for the index PE.